You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
All across Europe, coronavirus vaccines are in scarce supply. But in France, they are also surprisingly unwanted: Recent polls suggest just 57% of the country intends to get vaccinated, whereas in the United Kingdom, 89% wants to get a shot for COVID-19. With persistent, world-leading rates of vaccine skepticism, France is adopting a new tactic to boost trust. A 35-member citizens' vaccine panel, built from a random but demographically representative slice of the country, met for the first time last month in an effort to steer government strategy on COVID-19 vaccinations. The panel is the latest in a surge of citizen assemblies that have been set up across Europe to grapple with thorny questions at the intersection of science and society.
